Medtronic has become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycemia and in extreme cases, death. Medtronic has received reports of hypoglycemia requiring medical intervention potentially related to this issue.
Are your MiniMed infusion sets part of the recall?
We urge you to review the patient information provided by Medtronic and see whether your supplies may be affected.
The Medtronic Diabetes team has issued a statement that they will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support customers throughout this process.